Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pomoni (formerly O-Liv) is a physician-founded biotechnology and health-wellness company specializing in high-phenolic olive oil and polyphenol-based therapeutics. The company utilizes a patented Molecular Stabilization Technology to encapsulate and preserve bioactive compounds like oleocanthal and hydroxytyrosol, ensuring long-term potency and bioavailability. Its flagship products include Phenolia, a multi-source polyphenol supplement, and HPLC-verified extra virgin olive oil sourced from Greek groves. Through its biotech platform, the company is also advancing a pipeline of small molecule therapeutics, including OL-JC2 for Alzheimer's disease, targeting chronic inflammatory and neurodegenerative conditions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on O-Liv.